Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.79B -1.3%
Revenue (ttm)	193.90M -16.5%
Net Income	4.82M -51.4%
EPS	2.01 -51.4%
Shares Out	2.40M
PE Ratio	371.72
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Nov 23, 2025

Volume	196
Average Volume	1,628
Open	n/a
Previous Close	749.70
Day's Range	740.30 - 759.90
52-Week Range	681.00 - 947.90
Beta	-0.39
RSI	46.40
Earnings Date	Apr 23, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In fiscal year 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.